Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC
Clinical trial NCT05831969 · UNKNOWN
Trial details
- NCT number
- NCT05831969
- Sponsor
- Shenyang Tenth People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2025-06-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.